Search research articles
Contact Us
Filters
Showing results (81-90 of 179) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2018
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies
Lawrence L'Italien, Olivia Orozco, Tinya Abrams, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 10, 2014
KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?
Rodney J Scott, Stephen B Fox, Jayesh Desai, et al.
International Journal of Cancer
|
August 14, 2015
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
Natalie Turner, Hui-Li Wong, Arnoud Templeton, et al.
Cancer Chemotherapy and Pharmacology
|
January 26, 2021
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours
Sunit Sarkar, Ben Tran, Lisa Horvath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2010
Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis
Moriko Ito, Louise Barys, Terence O'Reilly, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 31, 2017
Precision oncology using a clinician-directed, tailored approach to molecular profiling
Michael Lam, Ben Tran, Sophie Beck, et al.
Nature Medicine
|
September 23, 2024
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
Scott Kopetz, Danielle A Murphy, Jie Pu, et al.
Investigational New Drugs
|
July 8, 2018
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci, Montaser Shaheen, Ben Markman, et al.
Molecular & Cellular Proteomics : MCP
|
March 17, 2023
PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P<sub>3</sub> Effector Signaling in Colorectal Cancer
Michelle Palmieri, Bruno Catimel, Dmitri Mouradov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor
Anat Norden-Zfoni, Jayesh Desai, Judith Manola, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 179) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2018
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies
Lawrence L'Italien, Olivia Orozco, Tinya Abrams, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 10, 2014
KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?
Rodney J Scott, Stephen B Fox, Jayesh Desai, et al.
International Journal of Cancer
|
August 14, 2015
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
Natalie Turner, Hui-Li Wong, Arnoud Templeton, et al.
Cancer Chemotherapy and Pharmacology
|
January 26, 2021
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours
Sunit Sarkar, Ben Tran, Lisa Horvath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2010
Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis
Moriko Ito, Louise Barys, Terence O'Reilly, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 31, 2017
Precision oncology using a clinician-directed, tailored approach to molecular profiling
Michael Lam, Ben Tran, Sophie Beck, et al.
Nature Medicine
|
September 23, 2024
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
Scott Kopetz, Danielle A Murphy, Jie Pu, et al.
Investigational New Drugs
|
July 8, 2018
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci, Montaser Shaheen, Ben Markman, et al.
Molecular & Cellular Proteomics : MCP
|
March 17, 2023
PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P<sub>3</sub> Effector Signaling in Colorectal Cancer
Michelle Palmieri, Bruno Catimel, Dmitri Mouradov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor
Anat Norden-Zfoni, Jayesh Desai, Judith Manola, et al.
Page
of 18